Treating Co-Occurring Opioid Use Disorder in Mental Health Settings-Presentation And Q&A

Video Transcription

Video Summary

Dr. Brian Hurley, an addiction physician, gave a detailed presentation on the topic of studying co-occurring opioid use disorder in mental health settings. He discussed the importance of providing evidence-based care for individuals with serious mental illness and substance use disorders. Dr. Hurley emphasized the need for medications for opioid use disorder, such as buprenorphine, and the benefits they offer in reducing overdose and improving treatment retention. He also addressed the challenges and barriers in integrating substance use services into mental health settings. Dr. Hurley discussed the different medications available, including methadone, buprenorphine, and naltrexone, and their mechanisms of action. He explained that buprenorphine can be prescribed by clinicians who have an X-waiver, and that the training requirement for the X-waiver was recently eliminated. He highlighted the importance of individualizing treatment and assessing readiness for medication-based treatment. Dr. Hurley also emphasized the need for counseling and support services to be part of the treatment plan for individuals with opioid use disorder. He discussed the role of counseling in helping patients achieve recovery. Dr. Hurley concluded by highlighting the value of a medication-first approach and the need for integrating substance use services into mental health and general medical settings to improve outcomes for individuals with co-occurring disorders.

Keywords

co-occurring opioid use disorder

mental health settings

evidence-based care

buprenorphine

overdose reduction

treatment retention

substance use services

medication-based treatment

counseling support

integrating services